Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Commercial Sponsor
TG Therapeutics, Inc.
Scientific Title
A Phase 1 Pharmacokinetic and Pharmacodynamic Study of TG-1701, an Irreversible Bruton's Tyrosine Kinase Inhibitor, in Patients With B-Cell Malignancies